Dr. Annunziato is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
351 N Sumneytown Pike
Gwynedd, PA 19454
Education & Training
University of RochesterFellowship, Pediatric Infectious Diseases, 1991 - 1994
The University of Texas Health Science Center at San AntonioClass of 1988
Long Island Jewish Medical CenterResidency, Pediatrics
Certifications & Licensure
NY State Medical License 1990 - 2019
Publications & Presentations
PubMed
- 316 citationsEfficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50–59 YearsKenneth E. Schmader, Myron J. Levin, John W. Gnann, Shelly A. McNeil, Timo Vesikari
Clinical Infectious Diseases. 2012-04-01 - 1365 citationsA vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.Michael N. Oxman, Myron J. Levin, Gary R. Johnson, Kenneth E. Schmader, Sharon E. Straus
The New England Journal of Medicine. 2005-06-02 - 29 citationsSafety of Zoster Vaccine in Elderly Adults Following Documented Herpes ZosterVicki A. Morrison, Michael N. Oxman, Myron J. Levin, Kenneth E. Schmader, John C. Guatelli
The Journal of Infectious Diseases. 2013-08-15
Press Mentions
FDA Panel Votes to Approve Pfizer’s ShotDecember 10th, 2020- Why This Week’s Meeting of an FDA Advisory Panel on Covid-19 Vaccines MattersOctober 20th, 2020
FDA Gives Priority Review to BLA for Investigational Ebola VaccineSeptember 19th, 2019- Join now to see all
Grant Support
- Varicella Zoster Virus Reactivation And Its PreventionNational Institute Of Allergy And Infectious Diseases1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
